OBJECTIVES: Clinical polymorphism is a main feature of Q fever and, depending upon the geographic location, differences in its clinical picture have been described. The objective of this study was to determine the epidemiology, clinical features and prognosis of acute Q fever in our area. METHODS: From 1985 to 1999, consecutive cases of Q fever, presented as febrile syndrome and attended in a tertiary teaching hospital in Sevilla, Spain, were included and followed prospectively. RESULTS: Two hundred and thirty-one cases of acute Q fever were included. A non-focalized febrile syndrome lasting from 7 to 28 days (fever of intermediate duration) was the most frequent presentation (n=208, 90%). One hundred and forty-eight patients had hepatitis. Overall, 53% of the cases were urban and contact with animals was referred in 39% of the patients. No relationship between clinical presentation and possible route of infection was observed. Prognosis was excellent (100% cured), although in 18 patients fever was prolonged more than 28 days and three patients developed life-threatening organ affection. Antimicrobial treatment was more effective if it was administered in the first two weeks (median defervescence of fever: 3 days versus 5.5 days, p<0.01). CONCLUSIONS: Acute Q fever is a common cause of fever of intermediate duration, even in urban areas. Elevation of hepatic enzymes was the most frequent laboratory finding. Severe organ affection is uncommon and the overall prognosis of the disease is excellent. Early treatment seems to shorten the duration of the disease.
OBJECTIVES: Clinical polymorphism is a main feature of Q fever and, depending upon the geographic location, differences in its clinical picture have been described. The objective of this study was to determine the epidemiology, clinical features and prognosis of acute Q fever in our area. METHODS: From 1985 to 1999, consecutive cases of Q fever, presented as febrile syndrome and attended in a tertiary teaching hospital in Sevilla, Spain, were included and followed prospectively. RESULTS: Two hundred and thirty-one cases of acute Q fever were included. A non-focalized febrile syndrome lasting from 7 to 28 days (fever of intermediate duration) was the most frequent presentation (n=208, 90%). One hundred and forty-eight patients had hepatitis. Overall, 53% of the cases were urban and contact with animals was referred in 39% of the patients. No relationship between clinical presentation and possible route of infection was observed. Prognosis was excellent (100% cured), although in 18 patientsfever was prolonged more than 28 days and three patients developed life-threatening organ affection. Antimicrobial treatment was more effective if it was administered in the first two weeks (median defervescence of fever: 3 days versus 5.5 days, p<0.01). CONCLUSIONS:Acute Q fever is a common cause of fever of intermediate duration, even in urban areas. Elevation of hepatic enzymes was the most frequent laboratory finding. Severe organ affection is uncommon and the overall prognosis of the disease is excellent. Early treatment seems to shorten the duration of the disease.
Authors: A Psaroulaki; C Hadjichristodoulou; F Loukaides; E Soteriades; A Konstantinidis; P Papastergiou; M C Ioannidou; Y Tselentis Journal: Eur J Clin Microbiol Infect Dis Date: 2006-09 Impact factor: 3.267
Authors: Isabel Jado; Cristina Carranza-Rodríguez; Jesús Félix Barandika; Álvaro Toledo; Cristina García-Amil; Beatriz Serrano; Margarita Bolaños; Horacio Gil; Raquel Escudero; Ana L García-Pérez; A Sonia Olmeda; Ianire Astobiza; Bruno Lobo; Manuela Rodríguez-Vargas; José Luis Pérez-Arellano; Fernando López-Gatius; Francisco Pascual-Velasco; Gustavo Cilla; Noé F Rodríguez; Pedro Anda Journal: BMC Microbiol Date: 2012-06-01 Impact factor: 3.605
Authors: Cornelia C H Wielders; Annemarie M H Wuister; Veerle L de Visser; Monique G de Jager-Leclercq; Cornelis A R Groot; Frederika Dijkstra; Arianne B van Gageldonk-Lafeber; Jeroen P G van Leuken; Peter C Wever; Wim van der Hoek; Peter M Schneeberger Journal: PLoS One Date: 2014-03-10 Impact factor: 3.240
Authors: J Parra Ruiz; A Peña Monje; C Tomás Jiménez; M I Parejo Sánchez; D Vinuesa García; L Muñoz Medina; M A Martínez Pérez; F Garcia; J Hernández Quero Journal: Eur J Clin Microbiol Infect Dis Date: 2008-06-07 Impact factor: 5.103